Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McCarty

Showing results (421-430 of 5,098) with videos related to

Pageof 510
Sort By:
Medical Hypotheses|May 1, 1981
Aldosterone and the Gerson diet -- a speculationM F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Mark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for PreventionMark F McCarty
The American Journal of Clinical Nutrition|August 1, 1982
Chromium and insulinM F McCarty
Medical Hypotheses|August 1, 1982
"Nutritional insurance" supplementation and corticosteroid toxicityM F McCarty
The Journal of Rheumatology|March 1, 1981
Coexistent gout and rheumatoid arthritisD J McCarty
Medical Hypotheses|September 27, 2002
Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapyMark F McCarty
Medical Hypotheses|September 27, 2002
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysisMark F McCarty
Medical Hypotheses|September 19, 2003
Turning an 'Achilles' Heel' into an asset--activation of HIF-1alpha during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damageM F McCarty
Medical Hypotheses|May 22, 2001
Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethineM F McCarty
Pageof 510

Showing results (421-430 of 5,098) with videos related to

Sort By:
Pageof 510
Medical Hypotheses|May 1, 1981
Aldosterone and the Gerson diet -- a speculationM F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Mark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for PreventionMark F McCarty
The American Journal of Clinical Nutrition|August 1, 1982
Chromium and insulinM F McCarty
Medical Hypotheses|August 1, 1982
"Nutritional insurance" supplementation and corticosteroid toxicityM F McCarty
The Journal of Rheumatology|March 1, 1981
Coexistent gout and rheumatoid arthritisD J McCarty
Medical Hypotheses|September 27, 2002
Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapyMark F McCarty
Medical Hypotheses|September 27, 2002
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysisMark F McCarty
Medical Hypotheses|September 19, 2003
Turning an 'Achilles' Heel' into an asset--activation of HIF-1alpha during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damageM F McCarty
Medical Hypotheses|May 22, 2001
Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethineM F McCarty
Pageof 510